Register data support the long-term safety of the use of ultra-hypofractionated radiotherapy for localised prostate cancer previously seen in the phase 3 trial HYPO-RT-PC: ESTRO 2024 congress report

Forskningsoutput: Övriga bidragWebbpublicering/bloggpostForskning

Originalspråkengelska
FörlagEuropean Society for Radiotherapy and Oncology (ESTRO)
StatusPublished - 2024 juli 10

Ämnesklassifikation (UKÄ)

  • Cancer och onkologi

Citera det här